Procalcitonin To Reduce Antibiotics in Chronic Obstructive Lung Disease (ProToCOLD) (ProToCOLD)
Chronic Obstructive Lung Disease
About this trial
This is an interventional prevention trial for Chronic Obstructive Lung Disease focused on measuring Infection, Antibiotics, COLD
Eligibility Criteria
Inclusion Criteria:
3.3. Inclusion Criteria and Recruitment Doctors in Pulmonary Medicine Department, Bispebjerg Hospital, which is involved directly in the treatment of patients who are potential candidates can be created as "investigator" after proper information and training. Then, these doctors include patients. Inclusion is based on the following in-and exclusion criteria and after oral and written participant information.
Inclusion: The following criteria must all be met for the patient can be First The patient must have confirmed / suspected COPD, and must be hospitalized with COPD exacerbation.
Second The patient must be an adult (more than 18 years) and age. 3rd There must be a signed informed consent 4th Patients included only on weekdays.
Exclusion Criteria:
Exclusions: The following criteria should NOT be satisfied that the patient can be First The patient can not understand or relate to the oral or written information Second The patient has previously been involved in the study
Sites / Locations
- Dept. of Pulmonary Medicine
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Procalcitonin-guidance
Control - Standard of Care
Discontinuation of Antibiotics. Procalcitonin is measured on day 1/2, day 3, day 5 and day 7 (all days where the patient is still admitted to hospital and antibiotics are discontinued, whenever Procalcitonin is <0.15 ng/ml and dis-encouraged whenever Procalcitonin is <0.25 ng/ml
Antibiotics are administered according to current guidelines